VIRGINIA RETIREMENT SYSTEMS ET Al Invests $1.02 Million in Solventum Corporation $SOLV

Key Points

• Virginia Retirement Systems acquired 13,200 Solventum shares worth approximately $1.02 million during the second quarter, joining other institutional investors increasing their positions.
• Analyst sentiment remains positive: Solventum has a “Moderate Buy” consensus rating, with eight Buy, three Hold and one Sell rating. Recent price targets were raised to as high as $101, versus a consensus target of $92.80.
• Solventum reported quarterly adjusted earnings of $2.55 per share, beating estimates of $1.91, while revenue reached $2.21 billion and rose 2.2% year over year.

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Solventum Corporation (NYSE:SOLV - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 13,200 shares of the company's stock, valued at approximately $1,018,000.

A number of other institutional investors and hedge funds have also bought and sold shares of SOLV. BOKF NA boosted its position in shares of Solventum by 6.9% during the third quarter. BOKF NA now owns 2,193 shares of the company's stock valued at $160,000 after buying an additional 141 shares during the last quarter. Smartleaf Asset Management LLC raised its position in Solventum by 23.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 744 shares of the company's stock worth $60,000 after buying an additional 142 shares during the last quarter. NewEdge Advisors LLC raised its position in Solventum by 2.2% in the 1st quarter. NewEdge Advisors LLC now owns 6,707 shares of the company's stock worth $438,000 after buying an additional 144 shares during the last quarter. Deseret Mutual Benefit Administrators lifted its stake in Solventum by 39.5% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 516 shares of the company's stock valued at $41,000 after acquiring an additional 146 shares during the period. Finally, HB Wealth Management LLC lifted its stake in Solventum by 3.5% during the 1st quarter. HB Wealth Management LLC now owns 4,292 shares of the company's stock valued at $280,000 after acquiring an additional 147 shares during the period.

Analyst Ratings Changes

A number of brokerages have recently commented on SOLV. BTIG Research lifted their price target on shares of Solventum from $91.00 to $95.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. Wall Street Zen upgraded shares of Solventum from a "hold" rating to a "buy" rating in a research report on Saturday. Weiss Ratings upgraded shares of Solventum from a "hold (c+)" rating to a "buy (b-)" rating in a report on Tuesday, August 18th. UBS Group lifted their target price on shares of Solventum from $95.00 to $101.00 and gave the stock a "buy" rating in a research report on Thursday, August 6th. Finally, Stifel Nicolaus boosted their target price on shares of Solventum from $90.00 to $100.00 and gave the company a "buy" rating in a research note on Thursday, August 6th. Eight research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $92.80.

Solventum Trading Down 0.0%

Solventum stock opened at $87.43 on Monday. Solventum Corporation has a 52-week low of $62.38 and a 52-week high of $94.16. The company has a market cap of $14.88 billion, a P/E ratio of 10.69, a P/E/G ratio of 1.36 and a beta of 0.61. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 1.00. The business has a 50-day simple moving average of $85.15 and a two-hundred day simple moving average of $76.58.

Solventum (NYSE:SOLV - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.64. The firm had revenue of $2.21 billion for the quarter, compared to analysts' expectations of $2.15 billion. Solventum had a net margin of 17.26% and a return on equity of 25.09%. The business's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.69 EPS. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. Analysts predict that Solventum Corporation will post 7.22 EPS for the current year.

About Solventum

Solventum Corporation NYSE: SOLV is a global healthcare company that develops products and technologies intended to improve patient care, support healthcare professionals and increase the efficiency of healthcare delivery. The company serves hospitals, clinics, dental practices, laboratories, government agencies and other healthcare-related organizations.

Its offerings include medical and surgical products such as wound-care, skin-care, infection-prevention and surgical solutions; dental products and materials; and health information systems that support clinical documentation, coding, workflow and decision-making.

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Corporation (NYSE:SOLV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.